SEC 13F Intelligence

Swiss National Bank / BMY

Swiss National Bank’s Bristol-Myers Squibb Co Position

Does Swiss National Bank own Bristol-Myers Squibb Co (BMY)? Yes — 5.97M shares worth $362M (+0.21% of its 13F portfolio) as of Q1 2026, up from 5.58M shares the prior filed quarter.

Position Value
$362M
Q1 2026
Shares
5.97M
% of Portfolio
+0.21%
Quarters Held
30
currently held

Position History BMY

Reported value by quarter
Q4 ’18: $280MQ4 ’18Q1 ’19: $264MQ2 ’19: $246MQ3 ’19: $279MQ4 ’19: $481MQ4 ’19Q1 ’20: $514MQ2 ’20: $531MQ3 ’20: $538MQ4 ’20: $535MQ4 ’20Q1 ’21: $556MQ2 ’21: $610MQ3 ’21: $523MQ4 ’21: $527MQ4 ’21Q1 ’22: $702MQ2 ’22: $728MQ3 ’22: $656MQ4 ’22: $624MQ4 ’22Q1 ’23: $585MQ2 ’23: $486MQ3 ’23: $392MQ4 ’23: $335MQ4 ’23Q1 ’24: $330MQ2 ’24: $249MQ3 ’24: $311MQ4 ’24: $324MQ4 ’24Q1 ’25: $349MQ2 ’25: $285MQ3 ’25: $265MQ4 ’25: $301MQ4 ’25Q1 ’26: $362Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20265.97M$362M+0.21%
Q4 20255.58M$301M+0.18%
Q3 20255.87M$265M+0.15%
Q2 20256.16M$285M+0.17%
Q1 20255.72M$349M+0.25%
Q4 20245.73M$324M+0.22%
Q3 20246.02M$311M+0.20%
Q2 20246.00M$249M+0.17%
Q1 20246.09M$330M+0.23%
Q4 20236.53M$335M+0.25%
Q3 20236.76M$392M+0.31%
Q2 20237.60M$486M+0.33%
Q1 20238.44M$585M+0.40%
Q4 20228.68M$624M+0.45%
Q3 20229.23M$656M+0.47%
Q2 20229.46M$728M+0.49%
Q1 20229.61M$702M+0.40%
Q4 20218.45M$527M+0.32%
Q3 20218.83M$523M+0.33%
Q2 20219.14M$610M+0.38%
Q1 20218.80M$556M+0.37%
Q4 20208.62M$535M+0.38%
Q3 20208.92M$538M+0.42%
Q2 20209.04M$531M+0.45%
Q1 20209.21M$514M+0.55%
Q4 20197.49M$481M+0.49%
Q3 20195.50M$279M+0.30%
Q2 20195.42M$246M+0.27%
Q1 20195.54M$264M+0.29%
Q4 20185.39M$280M+0.36%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Swiss National Bank’s full portfolio or all institutional holders of BMY.